Dinesen Puckett (catsupwhorl6)

The role of transfusion medicine consultative services in prospectively auditing (PA) orders for four-factor prothrombin complex concentrate (4F-PCC) was evaluated at an academic medical center. Data from 4 years of 4F-PCC orders were obtained from the laboratory information system, and electronic health records of patients receiving concentrate were reviewed. 4F-PCC was ordered for 427 patients with warfarin-, apixaban-, or rivaroxaban-associated hemorrhage. Turnaround time (TAT) to prepare 4F-PCC was longer when PA-recommended dose adjustments were needed (85 vs 66 minutes, P = .03). There was no difference in TAT between patients who died and those who were ultimately discharged (60 vs 70, P = .22). TAT was shortest for orders originating in the emergency department (ED) compared with other locations (64 vs 85, P < .001), and ED TAT was not associated with patient outcomes in ED patients. PA and dose adjustments reduced amounts of concentrate issued by 27 IU per dose (P = .01). Median international normalized ratio less than 1.3 after 4F-PCC transfusion was achieved for all anticoagulants after dose adjustments. PA did not affect order cancellation or product wastage rates. PA can ensure 4F-PCC is dosed appropriately without affecting patient outcomes. PA can ensure 4F-PCC is dosed appropriately without affecting patient outcomes.No Abstract Available. Controversy over the efficacy of homeopathic medicine is rooted in the view that its methodology is implausible. The study intended to explore the postintervention results for a randomly selected group of patients in an actual practice. The study was a retrospective review of the charts of patients receiving homeopathy, performed as a pilot study. The study took place at a part-time, urban practice in the Mid-Atlantic USA with an area population of about 600 000. The charts of 53 patients were randomly sampled for later abstraction and were included in the study. They were admitted between August 2010 and June 2014 for first-time visits and took part in at least one follow-up visit during the six months after the intervention. A standardized tool was used to abstract the data from patients' charts. After exclusions and losses to follow-up, data from 40 charts were analyzed. check details The actual number of visits after the initial visit that was included in the analysis varied from one to five. The current st these improvements can't be determined from available data, but the results do pose important questions about how humans heal. While other factors might account for this result, it's difficult to fully dismiss the idea that homeopathic medicine may have had some impact on observed results. The current study of the treatment experience of 40 persons with a variety of medical conditions found that a majority of patients, when their charts were analyzed according to specific criteria, experienced improvements while undergoing classical homeopathic treatment. The reasons for these improvements can't be determined from available data, but the results do pose important questions about how humans heal. While other factors might account for this result, it's difficult to fully dismiss the idea that homeopathic medicine may have had some impact on observed results.No Abstract Available.No Abstract Available.Cerebral ischemia-reperfusion induces mitochondrial fragmentation and dysfunction, which plays a critical role in the subsequent neuronal death and neurological impairment. Protection of mitochondria is an effective strategy to prevent neuronal damage after cerebral ischemia-reperfusion injury. USP30 is a deubiquitinating enzyme that localizes to the outer mitochondrial membrane. USP30 participates in the regulation of mitophagy and maintenance of mitochondrial morphology. In this study, the neuroprotective effect of USP30 and the underlying mechanisms were